Botulism
is a paralytic neuromuscular disorder caused by the toxin of a bacterium,
Clostridium botulinum.
Clostridium
botulinum
Clostridium
botulinum is a ubiquitous gram-positive, spore forming, obligate
anaerobe found in soil and marine environments throughout the world.
In the United States, food-borne botulism has been associated primarily
with home canned foods, particularly vegetables, fruit, and condiments,
and less commonly with meats and fish. There are seven distinct types
of the toxin, but human poisoning is usually caused by Type A, B, E,
or F. Type E outbreaks are frequently associated with fish products.
Although uncommon, the spores can be aerosolized by soil tilling, road
work, or dust storms.
Naturally occurring
botulism is the disease that results from the absorption of botulinum
toxin into the circulation from a mucosal surface (usually the gut in
adults and the lung in infants) or a wound. The toxin does not penetrate
intact skin and does not cross the blood-brain barrier. The toxin irreversibly
blocks the peripheral cholinergic synapses throughout the body, most
importantly at the neuromuscular junction. This blockage prevents the
release of the neurotransmitter acetylcholine
from the terminal end of motor neurons. This leads to muscle paralysis,
including the diaphragm, and in severe cases can lead to the need for
mechanical respiration to prevent a patient's suffocation.
Bioterrorism
Botulinum toxin
poses a major bioweapons threat because of its extreme potency and lethality.
Prolonged intensive care is often necessary for affected persons. Botulinum
toxin is probably the single most poisonous substance known to man --
extremely small quantities can have lethal results. Because toxin-containing
foods may place others who eat them at risk, and because of the potential
use of botulinum toxin as a biological weapon, public health officials
consider any case of botulism to be a significant event and all cases
should be reported immediately to state and local public health officials.
Three
Manifestations of Botulism
The bacterial
toxin typically acts in the intestine (an enterotoxin)
and causes systemic poisoning. There
are three generally recognized types of botulism: foodborne, wound,
and infantile:
The onset of botulism
generally occurs twelve to thirty-six hours after the toxin is ingested.
However, the incubation period may vary from a few hours to several days.
Symptoms can range from mild to severe. Constipation is characteristically
an early sign, reflecting formation of toxin within the GI tract, although
this is frequently overlooked. There is a specialized test to detect toxin
in serum by bioassay; however, this may be negative, particularly in wound
and infant botulism. Therefore, tests that confirm the presence of the
organism or its toxin in wounds, vomitus, gastric fluid, or stool are
much more effective.
Foodborne
Botulism
Cranial nerve
involvement often marks the onset of symptoms of foodborne botulism. Symptoms
may include dizziness, fatigue, headache, and the feeling of being agitated
and/or anxious. The affected individual's mental status remains unaffected.
Fever is usually minimal and may, in fact, be absent (afebrile). Affected
individuals may experience generalized muscle weakness, often progressing
rapidly from the head to involve the neck, arms, chest, and legs. The
weakness is usually not the same on both sides of the body (asymmetric).
Individuals may also experience nausea, vomiting, severe constipation
or diarrhea, and/or urinary retention. Abdominal pain may precede or follow
the onset of paralysis. Botulism may also produce progressive muscular
paralysis possibly abdominal distention characterized by the absence of
normal intestinal sounds. Paralytic obstruction of the intestines (ileus)
may also occur.
Eye symptoms may
include double vision (diplopia) and/or blurred vision, impaired functioning
of the muscles of the eyes (ophthalmoplegia), droopy eyelids (ptosis),
an abnormal intolerance of light (photophobia), dilation of the pupil
(mydriasis), and an involuntary rapid movement of the eyeball (nystagmus).
Some individuals
have difficulty speaking (dysphonia) or slurred speech (dysarthria). Symptoms
may also include difficulty in swallowing (dysphagia), a dry mouth and
very dry or sore throat. The gag reflex may be suppressed. Some individuals
have a tongue that is swollen and "coated."
Weakening of the
reflexes (hyporeflexia) may also be present. Pupillary reflexes may be
depressed and deep tendon reflexes may be normal or decreased. Some individuals
experience a sudden drop in blood pressure upon arising from a bed or
chair (postural hypotension) or a rapid heartbeat (tachycardia). Difficulty
breathing, irregular rate of respiration, and breathing characterized
by rhythmic waxing and waning of the depth of respirations, which may
be accompanied by periods of apnea (Cheyne-Stokes respiration), may also
be present.
Wound
Botulism
Wound botulism
is characterized by the same neurological symptoms as foodborne botulism.
However, the affected individual experiences no gastrointestinal symptoms
nor is there any evidence implicating food as the cause. The skin must
be carefully checked for wounds. Wound botulism is common after traumatic
injury involving contamination with soil, after cesarean delivery, and
in individuals with a chronic substance abuse problem. A fever due to
infection from other bacteria may be present.
Infant
Botulism
Infant botulism
may occur in infants less than 12 months of age. Constipation is initially
present in approximately two-thirds of these cases, followed by neuromuscular
paralysis. The severity of the disease varies among affected infants.
Affected individuals generally have been exposed to foods other than milk
contaminated with spores which are common in the environment. Cases have
been related to the ingestion of honey, vacuum cleaner dust, and soil
that contains C. botulinum.
The differential
diagnosis of infant botulism includes other causes of paralysis such as
Guillan-Barré syndrome (symmetric ascending paralysis with an elevated
CSF protein), poliomyelitits (asymmetric paralysis, fever, and CSF pleocytosis),
and myasthenia gravis (muscle fatigability with reversal or ptosis with
tensilon). In addition, bacterial sepsis and meningitis must always be
excluded in any infant presenting with fever, lethargy, and poor feeding.
The absence of a gag reflex, profound hypotonia, and hyporeflexia help
to differentiate infant botulism from bacterial sepsis. EMG (if abnormal)
typically show a pattern of brief duration, small-amplitude potentials
with a decremental response at low repetitive (3-10Hz) stimulation and
an incremental or staircase response at high repetitive stimulation.
The diagnosis
is confirmed by the detection of the organism or its toxin in the infants
stool. Toxin isolation and identification are accomplished via mouse lethality
testing, with typing confirmed by neutralization of the toxin by specific
sera.
Symptoms of the
following disorders can be similar to those of botulism. Comparisons may
be useful for a differential diagnosis.
-
Eaton-Lambert
Syndrome is a
neuromuscular disorder that may be an autoimmune disease. Major symptoms
include muscle weakness and fatigue especially of the pelvic and thigh
muscles. Other symptoms may include dryness of the mouth, impotence,
pain in the thighs, and a pricking, tingling or creeping sensation
on the skin (paresthesias) around the affected areas.
-
Guillain-Barre
Syndrome (acute idiopathic polyneuritis) is a very rare, rapidly
progressive disorder causing inflammation of the nerves (polyneuritis)
and paralysis. Although the precise cause of Guillain-Barre Syndrome
is unknown, a viral or respiratory infection precedes the onset of
the syndrome in about half of the cases. This has led to the theory
that Guillain-Barre Syndrome may be an autoimmune disease (caused
by the body's own immune system). Damage to the covering of nerve
cells (myelin) and nerve axons (the extension of the nerve cell that
conducts impulses away from the nerve cell body) results in delayed
nerve signal transmission. There is a corresponding weakness in the
muscles that are supplied with nerve impulses (innervated) by the
affected nerves.
-
Myasthenia
Gravis is a chronic neuromuscular disease characterized by weakness
and abnormally rapid fatigue of muscles, particularly those that are
controlled by the brain stem (bulbar-innervated). The symptoms of
Myasthenia Gravis typically improve following a period of rest. Any
muscle may be affected by this disorder. However, the muscles around
the eyes (extraocular) and those used in swallowing are most frequently
affected by Myasthenia Gravis.
Prevention
It is essential
that both home canned and commercially canned foods be prepared properly.
To prevent botulism, these foods must be adequately heated before serving.
Food that shows any sign of spoilage should be discarded. Unabsorbed toxin
may be eliminated by induction of vomiting, gastric lavage, and purgation.
Clostridium botulinum
spores are highly resistant to heat and may survive for several hours
at tempatures of 100°C. Exposure to moist heat at 120° centigrade
kills the spores. On the other hand, the toxins are readily destroyed
by heat. Therefore cooking food at 80°C for 30 minutes protects against
botulism. While home-canned food is the most common source for botulism,
commercially prepared foods have been implicated in about ten percent
of the cases. Vegetables, fish, fruits and condiments are the most commonly
involved; however beef, dairy products, pork, poultry, and other foods
have also been implicated. To reduce the risk of infant botulism it is
recommended that honey not be fed to infants who are less than 12 months
of age.
Medical
Treatment
Since respiratory
impairment and its complications may be life threatening, affected individuals
should be hospitalized and closely supervised. Prolonged artificial respiration
may be required.
Adult Care
Antibiotic therapy is not
indicated for the treatment of foodborne or infant botulism. For wound
botulism, antibiotic therapy may include agents such as penicillin G
or metronidazole. Intravenous equine (made from horses) antitoxin, administered
as early as possible in the course of illness, is the only specific
treatment available for foodborne and wound botulism. Equine antitoxin
can be toxic to babies with infantile botulism, however, so human botulism
immune globuline is prepared for infants. Antitoxin will not reverse
established neurological damage, but may prevent the progression of
disease, shorten the duration of ventilatory failure, and reduce the
period of hospitalization.
Trivalent antitoxin (A, B,
E) is available on a 24-hour basis from the Centers for Disease Control
in Atlanta, GA. They also supply a polyvalent antitoxin for specific
outbreaks that are due to Types C, D, or F botulism. Treatment should
be initiated as soon as possible. However, the risks of treatment must
be weighed against potential benefits. The antitoxins are made from
horse serum and there is the possibility, in some individuals, of anaphylaxis
or serum sickness. It may even be beneficial to begin treatment even
several weeks after ingestion of the toxin. While the use of antitoxin
does not reverse preexisting neurological impairment or the binding
of already bound toxin, it may possibly slow and halt further progression
of the disease.
Infant Care
Aggressive respiratory
and nutritional care (nasojejunal tube) are the mainstays of treatment.
Many infants require intubation and prolonged mechanical ventilation.
Continuous nasogastric feedings are preferred over bolus feedings to
minimize the risk of aspiration. Small volumes increased over a few
days are well tolerated and decrease the need for central hyperalimentation.
Physical and occupational therapies are crucial in maintaining range
of motion and functional positioning in patients. Antibiotics have not
shown to ameliorate the course of the disease. Aminoglycosides such
as gentamicin should be avoided for they may potentiate the neuromuscular
blockade. The role of human botulism immune globulin to modify the course
of the disease if administered early is being explored.
Prognosis for complete
recovery is excellent with meticulous supportive care. Infant botulism
is a self-limited disease lasting a total of 2 to 6 weeks with progressive
symptoms for 1 to 2 weeks followed by gradual recovery of motor function
over 3-4 weeks, as a result of the production of new nerve terminals
and motor-end plates. Relapse has been reported after apparent recovery,
thus necessitating close supervision and follow-up. It is universally
recommended that honey and corn syrup not be fed to infants less than
1 year old to prevent the occurrence of infant botulism.
Investigational
Therapies
Guanidine has been
used in the treatment of some patients affected with botulism. However,
reported results have been inconclusive and thus far the effectiveness
of the drug remains unproven. More studies are needed to determine the
long-term safety and effectiveness of this medication for the treatment
of botulism.
Equine antitoxin is
administered to individuals with wound botulism. The wound should be
thoroughly explored and cleaned. An antibiotic, such as penicillin,
should be given to eradicate C. botulinum from the site, even
though the benefit of this therapy is unproven. The wound should be
cultured and the results should help guide the use of other antibiotics.
Metronidazole may be an effective alternative to penicillin.
There is an experimental
botulism vaccine for laboratory workers.
Center for
Civilian Biodefense Strategies at Johns Hopkins University
Discussion
of Botulinum Toxin and Fact Sheet
NIH/National
Institute of Allergy and Infectious Diseases
9000 Rockville Pike
Bethesda MD 20892
3014965717
Centers for Disease Control
and Prevention
1600 Clifton Road NE
Atlanta, GA 30333
Telephone: (404) 639-3534
Food
and Drug Administration (FDA)
Office of Inquiry and Consumer Information
5600 Fisher Lane
Room 12-A-40
Rockville, MD 20857
Telephone: (301) 827-4420
Toll Free: (888) 463-6332
TEXTBOOKS
Bartlett JG. Botulism. In: Bennett JC, Plum F, eds. Cecil Textbook of
Medicine. 20th ed. Philadelphia, PA: W.B. Saunders Co; 1996:1635-36.
Abrutyn E. Botulism. In: Fauci AS, et al., eds. Harrison's Principles
of Internal Medicine, 14th Ed. New York, NY: McGraw-Hill, Inc; 1998:904-05.
Berkow R, ed. The Merck Manual-Home Edition. Whitehouse Station, NJ: Merck
Research Laboratories; 1997:516-18.
Beers MH, Berkow R, eds. The Merck Manual, 17th ed. Whitehouse Station,
NJ: Merck Research Laboratories; 1999:287-89
Bleck TP. Clostridium Botulinum. In: Mandell GL, et al., eds. Mandell,
Douglas and Bennett's Principles and Practice of Infectious Diseases.
4th ed. New York, NY: Churchill Livingstone Inc; 1995:2178-82.
REVIEW ARTICLES
Krishna S, et al. Infant botulism: case reports and review. J Ky Med Assoc.
2001;99:143-46.
Muensterer OJ. Infant botulism. Pediatr Rev. 2000;21:427.
Byrne MP, et al. Development of vaccines for the prevention of botulism.
Biochemie. 2000;82:955-66.
JOURNAL ARTICLES
Klein AW. Complications and adverse reactions with the use of botulinum
toxin. Semin Cutan med Surg. 2001;20:109-20.
Arnon SS, et al. Working Group on Civilian Biodefense. Botulinum toxin
as a biological weapon: medical and public health management. JAMA. 2001;285:1059-70.
Kakinuma H, et al. Application of nested polymerase chain reaction for
the rapid diagnosis of infant botulism type b. Acta Paediatr Jpn. 1997;
39:346-48.
Yamakawa K. Emergence of clostridium botulinum type b-like nontoxigenic
organisms in a patient with type b infant botulism. J. Clin Microbiol.
1997; 35:2163-64.
Maselli RA. Cluster of wound botulism in california:clinical, electrophysiologic,
and pathologic study. Muscle Nerve. 1997; 20:1284-95.
Zouari N, et al. Importance of electromyography in the diagnosis of botulism.
Neurophysiol Clin. 1997;27:220-26.
Angelo FJ, et al. A large outbreak of botulism: the hazardous baked potato.
J Infect Dis. 1998;178:172-77.